Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Juvenile × ruxolitinib × 30 days × Clear all

Sponsor

Conditions

Primary Myelofibrosis 5 Thrombocythemia, Essential 3 Myeloproliferative Disorders 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Polycythemia Vera 2 Myelodysplastic-Myeloproliferative Diseases 2 Myelodysplastic Syndromes 2 Leukemia 2 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma 1 Leukemia, Monocytic, Acute 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Graft vs Host Disease 1 Glioma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Bronchiolitis Obliterans Syndrome 1

Interventions

fludarabine 2 Biopsy 2 trametinib 1 thymoglobulin 1 omipalisib 1 merphos 1 imetelstat 1 hydrocortisone hemisuccinate 1 fludarabine phosphate 1 blinatumomab 1 Thiotepa 1 Spinal Puncture 1 Specimen Handling 1 Methotrexate 1 Mesna 1 Melphalan 1 Leucovorin 1 Hydrocortisone 1 Granulocyte Colony-Stimulating Factor 1 GRN163L peptide 1 Filgrastim 1 Cytarabine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡